Return to List
Study Summary
No.
2003-0460:
.......
Phase I Studies
......
Roy S. Herbst
......
Thoracic and Head and Neck Medical Oncology
.
Study Summary Title
Study Summary
Number:
2003-0460
Study Title:
A Phase I, First in Human, Open-Label, Dose Finding Study Evaluating the Safety and Pharmacokinetics of AMG 706 in Subjects with Advanced Solid Tumors
.
Physician
New Patient Referral
Name:
Roy S. Herbst
Patients Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Dept:
Thoracic and Head and Neck Medical Oncology
Referring MD
Call:
800-392-1611 (in U.S.A.) 713-792-6161 (outside U.S.A.)
Phone:
713-792-6363
Contact us about clinical trials
.
General Information
Disease Group:
Phase I Studies
Supported By:
Amgen
Phase of Study:
Phase I
Return
Visit:
Every 2 weeks after the first 8 weeks.
Treatment
Agents:
Imaging
Collection
Screening
amg 706
Home Care:
None
Treatment Loc:
outpatient
Estimated
Length of Stay
in Houston:
None
Description/
Intervention:
Unavailable
.
Study Objectives / Outcomes
Unavailable
.
Study Status Information
Study Activation / Registration Date:
07/17/2003
IRB Review and Approval Date:
06/18/2003
Study Type:
Therapeutic
Recruitment Status:
Terminated
Projected Accrual:
55
.
Enrollment Eligibility
If you do not meet the enrollment eligibility, there may be other treatment options for you.
Please Contact the
Referral Office
for more information.
Inclusion Criteria:
Patient is equal to or greater than 18 years of age.
Before any study-specific procedure, the IRB approved informed consent must be obtained.
.
Links
Registration Number:
Other Links:
.
Results
Return to Clinical Trials at M.D. Anderson Cancer Center